AIDS and Behavior

, Volume 17, Issue 1, pp 224–234 | Cite as

Early Uptake of HIV Clinical Care After Testing HIV-Positive During Home-Based Testing and Counseling in Western Kenya

  • Amy Medley
  • Marta Ackers
  • Manase Amolloh
  • Patrick Owuor
  • Helen Muttai
  • Beryl Audi
  • Manquins Sewe
  • Kayla Laserson
Original Paper


Home-based HIV testing and counseling (HBTC) has the potential to increase access to HIV testing. However, the extent to which HBTC programs successfully link HIV-positive individuals into clinical care remains unclear. To determine factors associated with early enrollment in HIV clinical care, adult residents (aged ≥13 years) in the Health and Demographic Surveillance System in Kisumu, Kenya were offered HBTC. All HIV-positive residents were referred to nearby HIV clinical care centers. Two to four months after HBTC, peer educators conducted home visits to consenting HIV-positive residents. Overall, 9,895 (82 %) of 12,035 residents accepted HBTC; 1,087 (11 %) were HIV-positive; and 737 (68 %) received home visits. Of those receiving home visits, 42 % reported HIV care attendance. Factors associated with care attendance included: having disclosed, living with someone attending HIV care, and wanting to seek care after diagnosis. Residents who reported their current health as excellent or who doubted their HBTC result were less likely to report care attendance. While findings indicate that HBTC was well-received in this setting, less than half of HIV-positive individuals reported current care attendance. Identification of effective strategies to increase early enrollment and retention in HIV clinical care is critical and will require coordination between testing and treatment program staff and systems.


HIV/AIDS HIV testing and counseling Antiretroviral therapy Kenya 


  1. 1.
    Kenya National Bureau of Statistics (KNBS), ICF Macro: Kenya demographic and health survey 2008–09. Available at (2010). Accessed 2 Feb 2012.
  2. 2.
    Crum NF, Riffenburgh RH, Wegner S, Agan B, Tasker S, Spooner K, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194–200.PubMedCrossRefGoogle Scholar
  3. 3.
    Lima V, Harrigan R, Bangsberg D, Hogg R, Gross R, Yip B, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50:529–36.PubMedCrossRefGoogle Scholar
  4. 4.
    Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, HPTN 052 Study Team, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.PubMedCrossRefGoogle Scholar
  5. 5.
    Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23:1397–404.PubMedCrossRefGoogle Scholar
  6. 6.
    Donnell D, Baeten JM, Kiaire J, Thomas KK, Stevens W, Cohen CR, Partners in Prevention HSV/HIV Transmission Study Team, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Kenya National AIDS Control Council. Kenya National AIDS Strategic Plan, 2009/2010–2012/13: delivering on universal access to services. Nairobi: National AIDS Control Council; 2009.Google Scholar
  8. 8.
    Adazu K, Lindblade KA, Rosen DH, Odhiambo F, Ofware P, Kwach J, et al. Health and demographic surveillance in rural western Kenya: a platform for evaluating interventions to reduce morbidity and mortality from infectious diseases. Am J Trop Med Hyg. 2005;73:1151–8.PubMedGoogle Scholar
  9. 9.
    Ombok M, Adazu K, Odihambo F, Bayoh N, Kiriinya R, Slutsker L, et al. Geospatial distribution and determinants of child mortality in rural western Kenya 2002–2005. Trop Med Int Health. 2010;15:423–33.PubMedCrossRefGoogle Scholar
  10. 10.
    Zeger S, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–30.PubMedCrossRefGoogle Scholar
  11. 11.
    Hatcher A, Turan J, Leslie H, Kanya L, Kwena Z, Johnson M, et al. Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav. 2012;16:1295–307.PubMedCrossRefGoogle Scholar
  12. 12.
    Assefa Y, Van D, Mariam DH, Kloos H. Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS. 2010;24:521–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Govindasamy D, van Schaik N, Kranzer K, Wood R, Matthews C, Bekker LG. Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. J Acquir Immune Defic Syndr. 2011;58(3):344–52.PubMedCrossRefGoogle Scholar
  14. 14.
    Govindasamy D, Ford N, Kranzer K. Risk factors, barriers, and facilitators for linkage to ART care in sub-Saharan Africa: a systematic review. AIDS. 2012; (epub).Google Scholar
  15. 15.
    Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDS. 2009;23:867–75.PubMedCrossRefGoogle Scholar
  16. 16.
    Zachariah R, Harries AD, Manzi M, Gomanj P, Teck R, Philips M, et al. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One. 2006;1:e121.PubMedCrossRefGoogle Scholar
  17. 17.
    Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658–65.PubMedCrossRefGoogle Scholar
  18. 18.
    Miller CM, Kelthapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health. 2010;15(suppl 1):48–54.PubMedCrossRefGoogle Scholar
  19. 19.
    Harries AD, Zachariah R, Lawn SD, Rosen S. Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. 2010;15(suppl 1):70–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7:234–44.PubMedCrossRefGoogle Scholar
  21. 21.
    Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo Zone Ethiopia: a case–control study. AIDS Res Ther. 2011;8:8.PubMedCrossRefGoogle Scholar
  22. 22.
    Lawn S, Harries A, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897–908.PubMedCrossRefGoogle Scholar
  23. 23.
    Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52:280–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Battegay M, Fluckiger U, Hirschel B, Furrer H. Late presentation of HIV-infected individuals. Antivir Ther. 2007;12:841–51.PubMedGoogle Scholar
  25. 25.
    Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV/AIDS. 2010;5:18–26.CrossRefGoogle Scholar
  26. 26.
    Lahuerta M, Lima J, Elul B, Okamura M, Alvim MF, Nuwagaba-Birbonwoha H, et al. Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr. 2011;58:e75–86.PubMedCrossRefGoogle Scholar
  27. 27.
    Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agabji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6:e11.PubMedCrossRefGoogle Scholar
  28. 28.
    Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82:299–307.PubMedGoogle Scholar
  29. 29.
    Rosen S, Fox M. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.PubMedCrossRefGoogle Scholar
  30. 30.
    Wachira J, Kimaiyo S, Ndege S, Mamlin J, Braitstein P. What is the impact of home-based HIV counseling and testing on the clinical status of newly enrolled adults in a large HIV care program in Western Kenya? Clin Infect Dis. 2012;54(2):275–81.PubMedCrossRefGoogle Scholar
  31. 31.
    Nakanjako D, Colebunders R, Coutinho AG, Kamya MR. Strategies to optimize HIV treatment outcomes in resource-limited settings. AIDS Rev. 2009;11:179–89.PubMedGoogle Scholar
  32. 32.
    Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793–800.PubMedCrossRefGoogle Scholar
  33. 33.
    World Health Organization: Patient monitoring guidelines for HIV care and antiretroviral therapy. Available at (2012). Accessed 10 Mar 2012.

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Amy Medley
    • 1
  • Marta Ackers
    • 1
  • Manase Amolloh
    • 2
  • Patrick Owuor
    • 2
  • Helen Muttai
    • 3
  • Beryl Audi
    • 2
  • Manquins Sewe
    • 2
  • Kayla Laserson
    • 2
    • 3
  1. 1.U.S. Centers for Disease Control and Prevention (CDC)AtlantaUSA
  2. 2.Kenya Medical Research Institute (KEMRI)NairobiKenya
  3. 3.U.S. Centers for Disease Control and Prevention (CDC)-KenyaNairobiKenya

Personalised recommendations